Merck KGaA (ETR:MRK – Get Free Report)’s stock price dropped 0.1% on Wednesday . The company traded as low as €129.85 and last traded at €130.75. Approximately 285,652 shares were traded during mid-day trading, The stock had previously closed at €130.85.
Merck KGaA Stock Up 4.5%
The firm has a market capitalization of $62.12 billion, a price-to-earnings ratio of 22.92, a P/E/G ratio of 2.37 and a beta of 0.78. The business’s 50-day moving average is €116.86 and its two-hundred day moving average is €119.17. The company has a debt-to-equity ratio of 40.47, a quick ratio of 0.72 and a current ratio of 1.51.
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.
Read More
- Five stocks we like better than Merck KGaA
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
